Respifral en es it fr

Respifral Brand names, Respifral Analogs

Respifral Brand Names Mixture

  • No information avaliable

Respifral Chemical_Formula


Respifral RX_link

Respifral fda sheet

Respifral FDA

Respifral msds (material safety sheet)

Respifral Synthesis Reference

No information avaliable

Respifral Molecular Weight

211.258 g/mol

Respifral Melting Point

170.5 oC

Respifral H2O Solubility

No information avaliable

Respifral State


Respifral LogP


Respifral Dosage Forms


Respifral Indication

For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitis

Respifral Pharmacology

Isoproterenol is a relatively selective beta2-adrenergic bronchodilator. Isoproterenol is indicated for the relief of bronchospasm associated with chronic obstructive pulmonary disease. The pharmacologic effects of beta adrenergic agonist drugs, including Isoproterenol, are at least in part attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3',5'- adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

Respifral Absorption

No information avaliable

Respifral side effects and Toxicity

No information avaliable

Respifral Patient Information

No information avaliable

Respifral Organisms Affected

Humans and other mammals